Insights on Multiple Myeloma Treatment Strategies

María Victoria Mateos; Heinz Ludwig; Ali Bazarbachi; Meral Beksac; Joan Bladé; Mario Boccadoro; Michele Cavo; Michel Delforge; Meletios A. Dimopoulos; Thierry Facon; Catarina Geraldes; Hartmut Goldschmidt; Roman Hájek; Markus Hansson; Krzysztof Jamroziak; Merav Leiba; Tamás Masszi; Larisa Mendeleeva; Michael O'Dwyer; Torben Plesner; Jesús F. San-Miguel; Christian Straka; Niels W.C.J. Van De Donk; Kwee Yong; Samo Zver; Philippe Moreau; Pieter Sonneveld

doi:10.1097/HS9.0000000000000163

Insights on Multiple Myeloma Treatment Strategies

María Victoria Mateos, Heinz Ludwig, Ali Bazarbachi, Meral Beksac, Joan Bladé, Mario Boccadoro, Michele Cavo, Michel Delforge, Meletios A. Dimopoulos, Thierry Facon, Catarina Geraldes, Hartmut Goldschmidt, Roman Hájek, Markus Hansson, Krzysztof Jamroziak, Merav Leiba, Tamás Masszi, Larisa Mendeleeva, Michael O'Dwyer, Torben PlesnerJesús F. San-Miguel, Christian Straka, Niels W.C.J. Van De Donk, Kwee Yong, Samo Zver, Philippe Moreau, Pieter Sonneveld

Samson Assuta Ashdod University Hospital

Research output: Contribution to journal › Review article › peer-review

32 Scopus citations

Abstract

The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.

Original language	English
Article number	e163
Journal	HemaSphere
Volume	3
Issue number	1
DOIs	https://doi.org/10.1097/HS9.0000000000000163
State	Published - 1 Feb 2019

ASJC Scopus subject areas

Hematology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/HS9.0000000000000163

Cite this

Mateos, M. V., Ludwig, H., Bazarbachi, A., Beksac, M., Bladé, J., Boccadoro, M., Cavo, M., Delforge, M., Dimopoulos, M. A., Facon, T., Geraldes, C., Goldschmidt, H., Hájek, R., Hansson, M., Jamroziak, K., Leiba, M., Masszi, T., Mendeleeva, L., O'Dwyer, M., ... Sonneveld, P. (2019). Insights on Multiple Myeloma Treatment Strategies. HemaSphere, 3(1), Article e163. https://doi.org/10.1097/HS9.0000000000000163

@article{ff7506a04e5445a4afb9ec15434b941c,

title = "Insights on Multiple Myeloma Treatment Strategies",

abstract = "The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.",

author = "Mateos, {Mar{\'i}a Victoria} and Heinz Ludwig and Ali Bazarbachi and Meral Beksac and Joan Blad{\'e} and Mario Boccadoro and Michele Cavo and Michel Delforge and Dimopoulos, {Meletios A.} and Thierry Facon and Catarina Geraldes and Hartmut Goldschmidt and Roman H{\'a}jek and Markus Hansson and Krzysztof Jamroziak and Merav Leiba and Tam{\'a}s Masszi and Larisa Mendeleeva and Michael O'Dwyer and Torben Plesner and San-Miguel, {Jes{\'u}s F.} and Christian Straka and {Van De Donk}, {Niels W.C.J.} and Kwee Yong and Samo Zver and Philippe Moreau and Pieter Sonneveld",

note = "Publisher Copyright: {\textcopyright} 2018 the Author(s). Published by Wolters Kluwer Health, Inc.",

year = "2019",

month = feb,

day = "1",

doi = "10.1097/HS9.0000000000000163",

language = "English",

volume = "3",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wolters Kluwer Health",

number = "1",

}

Mateos, MV, Ludwig, H, Bazarbachi, A, Beksac, M, Bladé, J, Boccadoro, M, Cavo, M, Delforge, M, Dimopoulos, MA, Facon, T, Geraldes, C, Goldschmidt, H, Hájek, R, Hansson, M, Jamroziak, K, Leiba, M, Masszi, T, Mendeleeva, L, O'Dwyer, M, Plesner, T, San-Miguel, JF, Straka, C, Van De Donk, NWCJ, Yong, K, Zver, S, Moreau, P & Sonneveld, P 2019, 'Insights on Multiple Myeloma Treatment Strategies', HemaSphere, vol. 3, no. 1, e163. https://doi.org/10.1097/HS9.0000000000000163

TY - JOUR

T1 - Insights on Multiple Myeloma Treatment Strategies

AU - Mateos, María Victoria

AU - Ludwig, Heinz

AU - Bazarbachi, Ali

AU - Beksac, Meral

AU - Bladé, Joan

AU - Boccadoro, Mario

AU - Cavo, Michele

AU - Delforge, Michel

AU - Dimopoulos, Meletios A.

AU - Facon, Thierry

AU - Geraldes, Catarina

AU - Goldschmidt, Hartmut

AU - Hájek, Roman

AU - Hansson, Markus

AU - Jamroziak, Krzysztof

AU - Leiba, Merav

AU - Masszi, Tamás

AU - Mendeleeva, Larisa

AU - O'Dwyer, Michael

AU - Plesner, Torben

AU - San-Miguel, Jesús F.

AU - Straka, Christian

AU - Van De Donk, Niels W.C.J.

AU - Yong, Kwee

AU - Zver, Samo

AU - Moreau, Philippe

AU - Sonneveld, Pieter

PY - 2019/2/1

Y1 - 2019/2/1

N2 - The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.

AB - The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.

UR - http://www.scopus.com/inward/record.url?scp=85088217785&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000163

DO - 10.1097/HS9.0000000000000163

M3 - Review article

C2 - 31723802

AN - SCOPUS:85088217785

SN - 2572-9241

VL - 3

JO - HemaSphere

JF - HemaSphere

IS - 1

M1 - e163

ER -

Insights on Multiple Myeloma Treatment Strategies

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this